Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

Management of metastatic radioiodine refractory differentiated thyroid cancer (DTC) can be a therapeutic challenge. Generally, little is known about the paired molecular profile of the primary tumor and the metastases and whether they harbor the same genetic abnormalities. The present study compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes-Lima, Cristiane J., Shobab, Leila, Wu, Di, Ylli, Dorina, Bikas, Athanasios, McCoy, Matthew, Feldman, Rebecca, Lee, Wen, Rao, Sarika N., Jensen, Kirk, Vasko, Vasily, Castro, Luiz Claudio, Jonklaas, Jacqueline, Wartofsky, Leonard, Burman, Kenneth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949910/
https://www.ncbi.nlm.nih.gov/pubmed/33716974
http://dx.doi.org/10.3389/fendo.2021.623182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949910/
https://www.ncbi.nlm.nih.gov/pubmed/33716974
http://dx.doi.org/10.3389/fendo.2021.623182

Ejemplares similares